These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

790 related items for PubMed ID: 20437580

  • 1. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH.
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [Abstract] [Full Text] [Related]

  • 2. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z, Li B, Xu D, Zhang Z, Zhao JM, Zhou G, Sun Y, Huang L, Fu J, Yang Y, Jin L, Zhang W, Zhao J, Sun Y, Xin S, Wang FS.
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [Abstract] [Full Text] [Related]

  • 3. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F.
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [Abstract] [Full Text] [Related]

  • 4. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F, Weber F, Huber S, Sotgiu S, Czlonkowska A, Holler E, Albert E, Weiss EH, Wekerle H, Hohlfeld R.
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [Abstract] [Full Text] [Related]

  • 5. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 6. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
    Vanderlocht J, Hendriks JJ, Venken K, Stinissen P, Hellings N.
    J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
    [Abstract] [Full Text] [Related]

  • 7. Depletion of functionally active CD20+ T cells by rituximab treatment.
    Wilk E, Witte T, Marquardt N, Horvath T, Kalippke K, Scholz K, Wilke N, Schmidt RE, Jacobs R.
    Arthritis Rheum; 2009 Dec; 60(12):3563-71. PubMed ID: 19950291
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J.
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [Abstract] [Full Text] [Related]

  • 9. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 10. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F, Raddatz D, Ho NA, Yeruva S, Dudas J, Ramadori G.
    Transl Res; 2007 Oct 15; 150(4):223-32. PubMed ID: 17900510
    [Abstract] [Full Text] [Related]

  • 11. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C, Nasorri F, Girolomoni G, Pità Od, Cavani A.
    Br J Dermatol; 2007 Aug 15; 157(2):249-58. PubMed ID: 17489975
    [Abstract] [Full Text] [Related]

  • 12. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F, Shi Y, Shirazian D, Morgante L, Miller A, Grob D.
    J Immunol; 1994 Jun 15; 152(12):6003-10. PubMed ID: 8207225
    [Abstract] [Full Text] [Related]

  • 13. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G, Stinissen P, Hauben L, Van den Berg-Loonen E, Raus J, Zhang J.
    Ann Neurol; 1997 Jul 15; 42(1):18-27. PubMed ID: 9225681
    [Abstract] [Full Text] [Related]

  • 14. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Jul 15; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 15. T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants.
    Te Boekhorst PA, Lamers CH, Schipperus MR, Hintzen RQ, van der Holt B, Cornelissen JJ, Löwenberg B, Gratama JW.
    Bone Marrow Transplant; 2006 Apr 15; 37(8):763-72. PubMed ID: 16518423
    [Abstract] [Full Text] [Related]

  • 16. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G, Angelucci F, Caggiula M, Nociti V, Iorio R, Patanella AK, Sancricca C, Mirabella M, Tonali PA, Batocchi AP.
    J Neurosci Res; 2006 Oct 15; 84(5):1027-36. PubMed ID: 16865709
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms.
    Frick LR, Rapanelli M, Cremaschi GA, Genaro AM.
    Brain Behav Immun; 2009 Jan 15; 23(1):36-40. PubMed ID: 18625298
    [Abstract] [Full Text] [Related]

  • 18. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM, Katz IR, Zucker MB, Thorbecke GJ.
    Cell Immunol; 1996 Sep 15; 172(2):205-16. PubMed ID: 8964082
    [Abstract] [Full Text] [Related]

  • 19. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D, Thomas AV, Petereit HF, Fink GR, Schroeter M.
    Neuroimmunomodulation; 2009 Sep 15; 16(6):385-91. PubMed ID: 19609087
    [Abstract] [Full Text] [Related]

  • 20. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B.
    Rev Neurol; 2009 Sep 15; 29(10):893-9. PubMed ID: 10637835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.